CAPTRUST Financial Advisors’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-18,234
| Closed | -$561K | – | 2258 |
|
|
2023
Q4 | $561K | Sell |
18,234
-12,319
| -40% | -$379K | ﹤0.01% | 1661 |
|
|
2023
Q3 | $683K | Sell |
30,553
-14,774
| -33% | -$330K | ﹤0.01% | 1434 |
|
|
2023
Q2 | $974K | Buy |
+45,327
| New | +$974K | ﹤0.01% | 1220 |
|
|
2022
Q3 | – | Sell |
-921
| Closed | -$16K | – | 2450 |
|
|
2022
Q2 | $16K | Sell |
921
-1,230
| -57% | -$21.4K | ﹤0.01% | 3486 |
|
|
2022
Q1 | $44K | Buy |
2,151
+1,062
| +98% | +$21.7K | ﹤0.01% | 2872 |
|
|
2021
Q4 | $20K | Sell |
1,089
-33
| -3% | -$606 | ﹤0.01% | 3276 |
|
|
2021
Q3 | $22K | Sell |
1,122
-73
| -6% | -$1.43K | ﹤0.01% | 3084 |
|
|
2021
Q2 | $28K | Buy |
1,195
+73
| +7% | +$1.71K | ﹤0.01% | 2880 |
|
|
2021
Q1 | $27K | Buy |
+1,122
| New | +$27K | ﹤0.01% | 2810 |
|